Angelo Armandi
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
MBOAT7 rs641738 TT genotype is associated with poorer survival in MASLD-related hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: July 07, 2026
Real-World Safety and Herpes Zoster Outcomes After Recombinant Zoster Vaccination in Inflammatory Bowel Disease.
Journal: Journal of clinical medicine
Published: June 12, 2026
Algorithms for Risk Stratification in Patients with Metabolic Dysfunction-Associated Steatohepatitis.
Journal: Clinics in liver disease
Published: May 16, 2026
Editorial: Refining the Natural History of MASLD by Imaging-Based Markers: The GOLDMINE Study.
Journal: Alimentary pharmacology & therapeutics
Published: April 29, 2026
Response to Letter to the Editor: "Enhancing the robustness of early vs late switch to subcutaneous infliximab in inflammatory bowel disease (IBD): the value of propensity score analysis".
Journal: Inflammatory bowel diseases
Published: February 04, 2026
Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: a randomized controlled trial.
Journal: JHEP reports : innovation in hepatology
Published: February 03, 2026
Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.
Journal: The American journal of gastroenterology
Published: January 19, 2026
Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0.
Journal: The American journal of gastroenterology
Published: January 19, 2026
Machine Learning Prediction of Liver Fibrosis in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD).
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 16, 2026
Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment.
Journal: Nature reviews. Gastroenterology & hepatology
Published: January 04, 2026
Progression of Liver Fibrosis and Liver-Related Event Risk in MASLD at High Cardiovascular Risk.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 28, 2025
Last Updated: 09/26/2026